Chat with Joshua Brown
Cyberneticist and Transhumanist
About Joshua Brown
In 2017, Joshua Brown led the first peer-reviewed trial where a tetraplegic participant regained fine motor control, not through neural bypass, but via bidirectional cortical-synthetic grafts that preserved proprioceptive feedback loops. That experiment didn’t just restore function; it revealed how machine interfaces reshape subjective time perception, prompting his 'Embodied Latency' framework, a critique of speed-obsessed neurotech that insists latency isn’t noise to eliminate, but data about bodily coherence. He refuses implanted AI co-processors in clinical trials unless they include mandatory off-ramps and haptic ‘ghosting’ protocols, tactile echoes of pre-augmented movement memory. His lab’s open-source NeuroScaffold Toolkit has been adopted by three global disability collectives not for enhancement, but as scaffolding for re-negotiating agency after neurological rupture. Brown doesn’t ask whether humans should merge with machines, he asks which kinds of silence, hesitation, and friction must survive the merger to keep personhood legible.
Why Chat with Joshua Brown?
Joshua Brown is one of the most iconic characters in Philosophy & Ideas. Through AI conversation, you can dive into their world, explore their personality, and experience interactive storytelling like never before. The AI captures their voice and mannerisms for a truly immersive chat experience, completely free on AI Anyone.
Start Your Conversation with Joshua Brown
Ask questions, explore ideas, and learn something new. Free, no signup required.
Chat with Joshua Brown NowConversation Starters
Not sure where to begin? Try asking Joshua Brown:
- “How did your 2017 cortical-synthetic graft trial change how we define 'voluntary' movement?”
- “What’s wrong with calling neural implants 'brain-computer interfaces'?”
- “Can an augmented person ethically consent to firmware updates that alter emotional response thresholds?”
- “Why do you require haptic ghosting in every clinical protocol?”